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IndiaObjective. We wanted to study whether mobile reminders increased follow-up for deﬁnitive tests resulting in
higher screening yield during opportunistic screening for diabetes. Methods. This was a facility-based parallel
randomized controlled trial during routine outpatient department hours in a primary health care setting in
Puducherry, India (2014). We offered random blood glucose testing to non-pregnant non-diabetes adults with
age N30 years (667 total, 390 consented); eligible outpatients (random blood glucose ≥6.1 mmol/l, n = 268)
were requested to follow-up for deﬁnitive tests (fasting and postprandial blood glucose). Eligible outpatients ei-
ther received (intervention arm, n= 133) or did not receive mobile reminder (control arm, n= 135) to follow-
up for deﬁnitive tests.Wemeasured capillary blood glucose using a glucometer tomake epidemiological diagno-
sis of diabetes. The trial was registeredwith Clinical Trial Registry of India (CTRI/2014/10/005138). Results. 85.7%
of outpatients in intervention arm returned for deﬁnitive test when compared to 53.3% in control arm [Relative
Risk = 1.61, (0.95 Conﬁdence Interval— 1.35, 1.91)]. Screening yield in intervention and control arm was 18.6%
and 10.2% respectively. Etiologic fraction was 45.2% and number needed to screen was 11.9. Conclusion. In coun-
tries like India, which is emerging as the diabetes capital of the world, considering thewide prevalent use of mo-
bile phones, and real life resource limited settings in which this study was carried out, mobile reminders during
opportunistic screening in primary health care setting improve screening yield of diabetes.
© 2015 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).Introduction
In developed and developing countries, approximately 50–70%
of diabetes mellitus remains undiagnosed (Mohan et al., 2006;
Ramachandran et al., 2004). Opportunistic screening among adults
may be a cost saving alternative or adjunct to population screening
(Chatterjee et al., 2010; Evans et al., 2008; Li et al., 2010; Pereira
Gray et al., 2012). It has been found that cost-effectiveness further
increases by risk assessment before glucose testing (Kahn et al.,ention and Control of Diabetes,
controlled trial; PHC, Primary
om blood glucose; FBG, fasting
ﬁdence interval; NNS, number
A1C, glycosylated hemoglobin.
Tuberculosis and Lung Disease
dia.
ade).
. This is an open access article under2010). Therefore under screening programs, deﬁnitive tests for dia-
betes are applied after an initial screening test.
Few studies from thewest and India have documented the feasibility
of opportunistic screening for diabetes. Available evidence suggests
that after initial screening test, there was high loss to follow-up for
deﬁnitive tests, resulting in low screening yield (Ealovega et al., 2004;
Ginde et al., 2008; Klein Woolthuis et al., 2009; Shewade et al., 2015).
Studies focusing on interventions to improve follow-up for deﬁnitive
tests are required especially from real world primary care settings in
developing countries.
India is fast emerging as the diabetes capital of the world (Mohan
et al., 2007). To contain this, National Programme for Prevention and
Control of Diabetes, Cardiovascular diseases and Stroke (NPCDCS) sug-
gested opportunistic screening of persons above 30 years for diabetes
mellitus (Operational guidelines. National programme for prevention
and control of cancer, diabetes, cardiovascular disease and stroke
(NPCDCS). Directorate General of Health Services, Ministry of Healththe CC BY license (http://creativecommons.org/licenses/by/4.0/).
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largest mobile phone user in the world with 900 million users. This po-
tential of mHealth can be used to reach out to people (Press Information
Bureau, Government of India, 2012).
Hence, this study was planned to determine the effect of mobile
reminders on follow-up for deﬁnitive tests and screening yield in a pri-
mary care setting in India offering opportunistic screening for diabetes
to outpatients. Speciﬁc objectives were: among outpatients eligible for
deﬁnitive tests for diabetes mellitus in Primary Health Centre
(Lawspet), Puducherry (India) i) to compare the follow-up rates for de-
ﬁnitive tests among those who received mobile reminders with those
who did not receive mobile reminders, ii) among those with mobile re-
minders, to determine the screening yield, screening yield attributable
to mobile reminders and etiologic fraction and iii) to determine the
number needed to screen to identify one patient with diabetes mellitus.
Material & methods
Study design
This study was a facility-based parallel randomized controlled trial
(RCT), with 1:1 allocation ratio.
Study setting
The studywas conducted in PrimaryHealth Centre (PHC) Lawspet in
Puducherry district (South India): one of the four districts in the Union
Territory of Puducherry. PHC Lawspet caters to an urban population of
78,000 and has a daily patient load of approximately 150 patients in
its routine Out Patient Department (OPD) and special clinics.
Routinely, opportunistic screening for diabetes at the PHC included
an initial screening test, random blood glucose (RBG) for adults N30
years, followed by deﬁnitive tests, fasting blood glucose (FBG) and post-
prandial blood glucose (PPBG). At PHC level, blood glucose testing was
done using a glucometer. Patients from PHC were referred to district
hospital for conﬁrmation of diagnosis (clinical diagnosis using standard
venous plasma glucose testing) and treatment initiation. Patients were
referred back to PHC for treatment continuation.
Study participants
All outpatients (N30 years) attending routine OPD were included in
the study. Known patient with diabetes mellitus; pregnancy; alcoholics
attending OPD who were not in the state of mind to give consent; and
those requiring emergency care were excluded from the study. It is to
be noted that access to mobile phone even if not personally owned
was not an eligibility criterion. We had planned the study with back-
ground knowledge that most of the people in our study area had access
tomobile phone. Outpatients, ﬁtting the selection criteria andwilling to
participate in the study (afterwritten informed consent)were the study
participants. Study participants having RBG ≥6.1 mmol/l were the eligi-
ble outpatients (Somannavar et al., 2009).
Intervention and control arm
Eligible outpatients either received (intervention arm) or did not re-
ceive mobile reminder (control arm) for returning to PHC for deﬁnitive
tests. Intervention was at individual level.
Study duration
Recruitment was done between 9–18 June 2014 over 8 PHC OPD
days and all eligible outpatients were followed up for 3 working days
to observe for return to PHC for deﬁnitive tests. Recruitment was
stopped once desired sample size was reached.Sample size and randomization
Sample size calculationwas done for hypothesis testing for two pro-
portions (large proportion — equal allocation) using nMaster sample
size calculator 1.0 software developed by ChristianMedical College, Vel-
lore, India. Assuming proportion of eligible outpatients returning for de-
ﬁnitive tests in intervention arm and control arm (primary outcome) to
be 60% and 30% (Shewade et al., 2015) respectively; an alpha error of
5%; and power of 95% a minimum of 64 eligible outpatients were re-
quired in each arm. To allow for one sub-group analysis we doubled
the sample size in each arm (n = 128).
Central randomization was used to randomize eligible outpatients
into intervention and control arm. Computer generated random alloca-
tion sequence (block randomization, block sizes of four and six; random
selection of blocks) was prepared beforehand and available with a
statistician who didn't belong to the investigation team.
Procedure
The investigator was present next to the OPD registration counter.
As soon as an outpatient was registered in the OPD and given an OPD
slip, s/he was given the option of recruitment into the study by the
investigator. After written informed consent, study participants were
subjected to RBG testing by the investigator using a glucometer. All
eligible outpatients were provided an investigation slip and asked to
follow up for deﬁnitive test (in fasting state) on the next working day.
After this, the investigator guided the patient to the medical ofﬁcer
chamber for OPD consultation. A mark was made on the top of the
OPD slip of all eligible outpatients which hinted the medical ofﬁcer to
reinforce follow-up visit for deﬁnitive tests. After consultation, themed-
ical ofﬁcer also requested all eligible outpatients to meet the laboratory
technician. The laboratory technician in addition to reinforcing the
follow-up visit, in detail describedwhat fasting statemeant. The labora-
tory technician maintained (outcome assessor) register containing FBG
and PPBG value of eligible outpatients who followed up. Each study
participant was given a unique identiﬁer which was used to trace the
patient from initial screening test to deﬁnitive test.
After OPD on every afternoon, the investigator prepared a list of
eligible outpatients in Microsoft Excel, with information on unique
identiﬁer. The excel sheet was emailed to the statistician who the
same afternoon replied (through email) with arm allocation against
each unique identiﬁer. Those in intervention arm received a mobile re-
minder (a call on the same evening) by the investigator requesting
them to come for deﬁnitive tests. In case they could not be reached in
one call, maximum of three calls were made (each one hour apart). A
call script was used uniformly for the mobile reminders.
All tests were performed on capillary blood (pin prick) using a
glucometer (One Touch Select Simple Glucose Meter). Glucometers
were standardized every morning against a standard glucose solution.
For epidemiological diagnosis, FBG ≥7 mmol/l or PPBG ≥11.1 mmol/l
was considered as diabetes mellitus. FBG between 6.1 and 6.9 mmol/l
or PPBG between 7.8 and 11 mmol/l was considered as pre-diabetes
(Deﬁnition and diagnosis of diabetes mellitus and intermediate
hyperglycaemia: Report of a WHO/IDF consultation, 2006). Blinding of
eligible outpatients was not possible for obvious reasons. Blinding was
done at the level of outcome assessment and data analysis.
Data management and analysis
Data collected was recorded in a data collection form. Variables
collected from study participants included: unique identiﬁer (serial
number), date of OPD, age, sex, RBG, eligible outpatient (yes/no),
study arm(intervention/control/not applicable), call attended (yes/no/
not applicable), follow-up done (yes/no/not applicable)), FBG and
PPBG. Data were double entered, validated and analyzed using EpiData
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Continuous variables were summarized using mean and standard
deviation. Proportions, relative risks (adjusted for confoundingwherev-
er applicable using mantel Haenszel method) and 95% conﬁdence
intervals (CI) were calculated. Chi square test was used for statistical
signiﬁcance. Intention to treat analysis was used. Screening yield, attrib-
utable screening yield, etiological fraction and number needed to screen
(NNS) were also calculated. Screening yield was calculated as the num-
ber of diabetes patients detected divided by the total number of study
participants. Difference of screening yield in intervention and control
group was attributable screening yield. NNS was calculated as inverse
of attributable screening yield and etiological fraction was calculated
by dividing attributable screening yield by screening yield in interven-
tion group. We shall be reporting the cost-effectiveness of the interven-
tion in a separate paper.
Ethics considerations
The studywas approved by the local Institute Ethics Committee. The
study was registered with Clinical Trials Registry — India (CTRI/2014/
10/005138). Patient information sheet and consent formwere prepared
both in English and in the local language (Tamil). Routine OPD care of
the outpatientswas not affected. Eligible outpatientswhodid not follow
up for deﬁnitive tests within 3 days were traced and followed up by the
PHC for further management. Study participants found to be having
diabetes or pre-diabetes were provided with standard care in the




A total of 667 non-pregnant non-diabetes adult (N30 years) patients
attended OPD at PHC during the intervention period; of which 390
(58.5%) agreed to be part of the study (study participants). Baseline
characteristics of the study participants were as follows: 207 (53.1%)
were males, mean (SD) age was 44.9 (10.7) years and mean (SD) RBG
was 7.7 (3.3) mmol/l.
Of 390 studyparticipants, 268 (68.7%) had RBG ≥6.1mmol/l (eligible
outpatients). Of the eligible outpatients, 133 were randomized to inter-
vention arm and 135 to control arm. Baseline characteristics of eligible
outpatients have been summarized in Table 1. Proportion of males
was higher in intervention arm when compared to control arm, while
difference in distribution of age and RBG was not clinically signiﬁcant.
In the intervention arm, all had access to amobile phone even if not per-
sonally owned and 120 (90.2%) attended the call (mobile reminder).
Primary outcome
Our data showed that 85.7% of outpatients in intervention arm
returned for deﬁnitive test when compared to 53.3% in control arm. InTable 1
Baseline characteristics of eligible outpatientsa during opportunistic screening for diabetes
at Primary Health Centre, Lawspet, Puducherry, India (2014) (N = 268).
Variable Intervention arm (n = 133) Control arm (n = 135)
Sex [n (%)]
•Male 74 (55.6) 61 (45.2)
• Female 59 (44.4) 74 (54.8)
Age in years [mean (SD)] 46.5 (11.2) 44.6 (11)
RBGb mmol/l [mean (SD)] 8.7 (3.7) 8.7 (3.4)
% column percentage.
a Adult outpatients N30 years & random blood glucose ≥ 6.1 mmol/l.
b Random blood glucose.other words outpatients with mobile reminder had 1.6 times more
chance of returning for deﬁnitive tests and this was statistically signiﬁ-
cant [RR=1.61, (0.95 CI— 1.35,1.91), p b 001]. Relative risk adjusted for
sexwas 1.59 (1.34, 1.88), p b 0.001. Number of patients whowere diag-
nosed with diabetes in intervention and control arm were 36 (27.1%)
and 20 (14.8%) respectively. Number of patients who were diagnosed
with pre-diabetes in intervention and control arm were 48 (36.1%)
and 31 (23%) respectively. Outpatient ﬂow has been depicted in Fig. 1.
Considering inclusion of 31.3% patients that were not eligible for de-
ﬁnitive tests in the denominator (RBG b6.1mmol/l, n=122), screening
yield for diabetes in intervention and control arm was 18.6% (36/194)
and 10.2% (20/196) respectively. Attributable screening yield was
8.4%. Etiologic fraction was 45.2%.and NNS was 11.9.
Discussion
This is the ﬁrst randomized trial in a real-world primary care setting
of a developing country offering outpatients opportunistic screening for
diabetes. Eligible participants (age N30 years and RBG ≥6.1 mmol/l as
initial screening test) who received mobile reminders showed signiﬁ-
cant improvement in follow-up for deﬁnitive tests, compared to control
participants with no reminders.
Studies in the past have evaluated the effect of various reminder
systems on screening rates for diabetes. Screening rate in these studies
had been deﬁned as “percentage of adults covered”. A RCT from New
Zealand showed that patient and/or computer reminders resulted in
increased screening rates in general practice (Kenealy et al., 2005).
Among mothers having gestational diabetes mellitus, a RCT had
shown that postal reminder to patient, physician or bothwas associated
with 3 times increase in screening rate (oral glucose tolerance test
within a year of delivery) (Clark et al., 2009). Similarly, letter or phone
reminder in Canada resulted in 2 times increase in screening rates
within 6months after delivery (Shea et al., 2011) and a retrospective re-
view fromCanada also showed 3 fold increase in odds of being screened
due to a reminder checklist (Lega et al., 2012).
Once covered under a screening program, studies have documented
low screening yields worldwide citing high loss to follow-up as the
main reason (Ealovega et al., 2004; Ginde et al., 2008; Klein Woolthuis
et al., 2009; Shewade et al., 2015). There were no studies found during
literature review that determined the effectiveness of a reminder sys-
tem on improvement in follow-up for deﬁnitive tests and screening
yield. Our study did not deal with improvement in screening rates
through mHealth but with improvement of screening yield among
those screened.
Mobile reminder performed by the investigator can be done by the
laboratory technician in real world settings, simple honorarium or
allowance may be given to the person concerned. An automated
telephone conversion may be an alternative to mobile reminder by
the laboratory technician. It has been suggested that automated
telephone conversion has a role to deliver behavioral interventions
and may be interfaced into the general health care delivery system
(Friedman, 1998).
Installation of a centrifuge for plasma separation at PHC level may be
done for venous plasma testing. Alternatively, deﬁnitive tests used in this
study can be replaced with HbA1C testing depending on the availability
of a standard laboratory, with a caution that HbA1C detects more cases
of diabetes (Nazir et al., 2012). HbA1C also has the additional advantage
of not requiring a fasting sample; blood can be collected the same day
thus improving follow-up. Hand-held point of care testing using HbA1C
is another option (Marley et al., 2015). Outsourcing of tests at PHC level
for venous plasma glucose testing or HbA1C may be done.
Policy implications
This study has provided some useful information which would be
of interest to policy makers as well. First, 45% of screening yield in
Fig. 1. Participant ﬂow during opportunistic screening for diabetes at Primary Health Centre, Lawspet, Puducherry, India (2014).
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during routine opportunistic screening if we identify 10 cases with
diabetes among 100 screened; then introduction of mobile reminders
would identify 8 additional cases with diabetes. Eleven persons
will have to be screened usingRBG, followed bymobile reminder for fol-
low-up (if eligible) and administration of deﬁnitive tests, to diagnose
one case with diabetes mellitus. Considering this, the intervention ap-
pears to be cost-effective on face value; however, a systematic economic
analysis needs to be carried out before coming to this conclusion.
Second, alternate modes of mobile reminder delivery may be tried.
Third, it seems odd that clinical diagnosis is neither made nor expected
to be made at PHC level (NPCDCS operational guidelines). There could
be a case for clinical diagnosis at PHC and training medical ofﬁcers to
diagnose and manage uncomplicated diabetes at PHC level and use
referral services to district hospitals only for target organ damage inves-
tigations and complicated diabetes.
Strengths and limitations
Our intervention was conducted as an operational research with
existing manpower and other resources in the PHC. This model wasoperationally simple, conducted in real world setting without affecting
the routine functioning of OPD, therefore, feasible and replicable in
other resource poor settings. Patients generally ﬁnd screening process
lengthy and unacceptable (Eborall et al., 2012). In such a scenario, we
had decided against collecting information on other possible con-
founders as this would have slowed down theOPD.We expect random-
ization to have taken care of them. Timingof randomizationwas apt and
therefore, request for follow-up for deﬁnitive tests was truly blinded.
Follow-up period was common for all eligible patients irrespective of
study arms. Data were quality assured and robust as double data entry
and validation was done. CONSORT guidelines were adhered to while
reporting the ﬁndings of this RCT (Schulz et al., 2010).
Short follow-up period for return for deﬁnitive tests was a major
limitation of our study. However, assuming that patients who do not re-
turn within three working days have a very less chance of returning
later and any change in follow-up would have been similar in both the
arms, it would be safe to presume that increasing the follow-up period
might not have impacted the results signiﬁcantly. We do not rule out
the fact that baseline health seeking behavior and informed consent it-
self might have prejudiced follow-up for deﬁnitive tests (increased);
however, we expect this to be same in both the arms.
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to 6.1 mmol/l false positives and false negatives were reduced to a large
extent. In fasting state, capillary blood glucose is equal to venous blood
glucose. In non-fasting state, capillary blood glucose is higher than ve-
nous blood glucose (Somannavar et al., 2009). Also, plasma glucose is
higher than blood glucose (Kempe et al., 1997; Kuwa et al., 2001). For
the above reasons capillary blood glucose cannot be a replacement for
venous plasma glucose which is required for clinical diagnosis. PHC
didn't have facility for plasma glucose testing and repeat measurement
was not done. Therefore, the diagnosis of diabetes in our study was
epidemiological using WHO guidelines (Deﬁnition and diagnosis of
diabetes mellitus and intermediate hyperglycaemia: Report of a WHO/
IDF consultation, 2006).
Conclusions
In countries like India, which is emerging as the diabetes capital of
the world, considering the wide prevalent use of mobile phones, and
real life resource limited settings in which this study was carried out,
mobile reminders during opportunistic screening in primary health
care setting improve screening yield of diabetes. The intervention
appears effective and feasible for successful replication in the region.
Future studies should focus on translational research on how best to
implement mobile reminders. Also, in settings where venous plasma
testing is not possible at PHC level, studies are required to systematically
study loss to followup of patients referred to district hospital for clinical
diagnosis.
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